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-Disc Genes in
ypertrophic Cardiomyopathy
tretching the Cardiomyopathies?*
. Martijn Bos, MD, PHD,†
ichael J. Ackerman, MD, PHD†‡
ochester, Minnesota
ypertrophic cardiomyopathy (HCM) is a disease charac-
erized by unexplained left ventricular hypertrophy. Occur-
ing in about 1 in 500 individuals, HCM is the most
ommon heritable cardiovascular disease, most often follow-
ng an autosomal-dominant inheritance pattern with in-
omplete penetrance and variable expressivity. Initially,
CM was considered a disease of the sarcomere in lieu of
he discovery of mutations involving the MYH7-encoded
eta-myosin heavy chain and subsequently other neighbor-
ng sarcomeric proteins (1,2). Presently, clinical genetic
esting for HCM includes the 9-gene panel for sarcomeric
r myofilament HCM, which explains up to 65% of genetic
CM in selected cohorts. With a large portion of HCM
enetically unexplained, genes encoding proteins involv-
ng various functional or transcriptional processes of the
See page 1127
ardiomyocyte have been associated with disease pathogen-
sis, particularly genes that encode the constellation of
roteins localizing to the cardiac Z-disc. The Z-disc com-
lex of proteins is located at either end of the contractile
lements of the myofilament and is interconnected by the
iant, sarcomere-stretching protein titin (encoded by TTN).
ecause of its close proximity to the contractile apparatus,
ts specific structure–function relationship with regard to
yto-architecture, and its role as the stretch-sensor mecha-
ism of the sarcomere, genes encoding these Z-disc proteins
ere hypothesized to be excellent candidate genes in the
athogenesis of HCM. Mutations in 7 Z-disc genes have
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Mayo Clinic Windland Smith Rice Sudden Death Genomics Labora-
ory, Rochester, Minnesota, and the ‡Departments of Medicine, Pediatrics, and
olecular Pharmacology and Experimental Therapeutics/Divisions of Cardiovascular
iseases and Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota. Dr. Acker-Z
an is a consultant for Medtronic, St. Jude Medical, Boston Scientific, and
GxHealth, and has received royalties from PGxHealth.ince been described (Table 1), of which some are currently
vailable for clinical genetic testing for HCM and/or dilated
ardiomyopathy (DCM).
In this issue of the Journal, Chiu et al. (3) describe the
esults of their study on a 23-member family of patients
ith predominantly HCM and features of atrial fibrillation,
eart failure, and sudden death. However, some family
embers also showed signs less characteristic for HCM,
uch as right ventricular hypertrophy, possible arrhythmo-
enic right ventricular cardiomyopathy (ARVC), and apical
rabeculations. Linkage analysis identified a locus involving
9 genes, of which 2—RYR2-encoded cardiac ryanodine
eceptor and ACTN2-encoded alpha-actinin-2—were se-
ected for subsequent genetic analysis based on biological
lausibility. This analysis elucidated the family’s HCM-
ausative mutation in ACTN2 with proper cosegregation of
utation and disease phenotype. An ACTN2–HCM link
as further bolstered by the discovery of additional ACTN2
ene mutations in an independent cohort of probands with
CM.
With the discovery of yet another Z-disc–associated
CM-susceptibility gene, a number of interesting ques-
ions surrounding the role of this myriad of proteins in the
athogenesis of HCM emerge. What is the role of muta-
ions in Z-disc genes in the pathogenesis of HCM, and why
oes there seem to be such a large pleiotropic overlap, even
ithin families, with other cardiomyopathies, such as
CM, ARVC, and even left ventricular noncompaction
LVNC)? Is there a specific Z-disc HCM phenotype, and
hat other genes encoding the large cluster of proteins
omposing the Z-disc will emerge as pathogenic substrates
or heritable cardiomyopathies?
First of all, it is striking that most HCM-susceptibility
-disc genes are also associated with the pathogenesis of
CM, with both phenotypes sometimes seen in the same
amily (4–12). Of course, this pleiotropism has been noted
reviously for perturbations in the cardiac myofilaments,
here mutations in cardiac actin were first reported to cause
ot only DCM but also HCM (5,13). Pathogenetically, for
he myofilaments, one can invoke domain-specific dysregu-
ation whereby the particular cardiomyopathy (DCM vs.
CM) emerges depending on whether the mutation in a
iven myofilament gene disrupts a force-generating domain
HCM) or a force-transmitting domain (DCM) within the
ncoded protein (5,13). For Z-disc–mediated cardiomy-
pathies, however, it is more difficult to envision just how
he 2 divergent, cardiomyopathic phenotypes emerge,
specially because, given the Z-disc’s role as the sar-
omere’s stretch sensor and mechanoreceptor, maladap-
ive dilation seems a more plausible phenotypic response
han maladaptive hypertrophy.
Elucidating the specific phenotype or phenotypes of
-disc HCM will help answer some of the intriguing
uestions surrounding this genetic subset of HCM. Initial
-disc genotype/HCM phenotype studies suggest that
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March 16, 2010:1136–8 Z-Disc HCM-disc HCM is associated preferentially with a sigmoidal-
haped septal contour, whereas myofilament HCM shows
referentially a reverse septal curvature (14,15). However,
ndividual cohort studies still lack the power to establish a
articular Z-disc HCM phenotype. With more mutations
eing discovered in Z-disc genes in different cohorts,
erhaps either a meta-analysis of the current literature or a
ollaborative effort between the different research groups
ight be able to shed light on this issue. Increasing the total
umber of patients with a mutation in 1 of the Z-disc genes
ould reveal a distinct Z-disc phenotype to help answer
ome of these questions. Is there a different age of onset of
he disease compared with myofilament- or genotype-
egative HCM? Are families indeed more likely to show
ixed HCM phenotypes of HCM and DCM, and possibly
RVC or LVNC? And are there any other features that
ake this genotypic subset different from the other?
Aside from larger genotype–phenotype analyses and the
ecessary functional analyses to further understand the
athogenic mechanisms underlying Z-disc HCM, this re-
ion of the cardiac sarcomere is fertile ground for the
dentification of novel cardiomyopathic substrates. For ex-
mple, as one of the central proteins of the Z-disc, ACTN2
inds to a large number of proteins, including ALP-encoded
ctinin-associated LIM protein (16), CapZ-encoded actin-
apping protein (17), or S100, of which the S100B isoform
eems to function as an inhibitor of the hypertrophic
esponse (18). ALP, CAPZ, and S100 may represent the
ext tier of HCM candidate genes that will expand the
pectrum of Z-disc HCM.
However, ACTN2 not only binds to structural partners
n the Z-disc, but also has been shown to interact directly
ith ion channels of the cardiomyocyte, such as the Kv7.1
nd the Kv1.5 potassium channels (encoded by KCNQ1 and
CN5A, respectively), as well as found to serve as a bridge
etween the Cav1.3 and Cav1.2 calcium channels (19,20).
ncreasing the intrigue of the current finding is a report by
huiyan et al. (21) in 2007, in which linkage analysis was
erformed on 16 members from 2 separate families with
atecholaminergic polymorphic ventricular tachycardia
CPVT). In addition to exercise-related ventricular arrhyth-
ias, pathognomic for CPVT, family members also showed
ummary of HCM-Susceptibilityenes That Encode Z-Disc ProteinsTable 1 Summary of HCM-SusceptibilityGenes That Encode Z-Disc Proteins
Gene Locus Protein Frequency (%)
ACTN2 1q42-q43 Alpha-actinin-2 1
ANKRD1 10q23.33 Ankyrin repeat domain-1 1
CSRP3 11p15.1 Muscle LIM protein 1
LBD3 10q22.2-q23.3 LIM binding domain-3
(alias: ZASP)
1–5
MYOZ2 4q26-q27 Myozenin-2 1
TCAP 17q12-q21.1 Telethonin 1
VCL 10q22.1-q23 Vinculin/metavinculin 1
CM  hypertrophic cardiomyopathy.ome atypical features for the CPVT phenotype, includinginoatrial and atrioventricular nodal dysfunction, atrial
tandstill, and even left ventricular dysfunction and dilata-
ion. Interestingly, their analysis narrowed in on the exact
ame locus as that found by Chiu et al. (3) (chromosome
q42-q43), but instead of point mutations in either RYR2
r ACTN2, large genomic deletions of RYR2 were discov-
red as causative for the disease in this family (21).
The finding by Chiu et al. (3) validates the role of
CTN2 and Z-disc genes in the pathogenesis of HCM and
aves the way for future studies into the characteristics of
his interesting subset of genetic HCM. Not only does it
how the role of the Z-disc and ACTN2 in the development
f a variety of cardiomyopathies, it also opens the door to
tudy the role of the Z-discs and their interactions with
ardiac ion channels, their associated diseases, and possibly
ven a final common pathway for all cardiomyopathies (22).
eprint requests and correspondence: Dr. J. Martijn Bos, Mayo
linic, Windland Smith Rice Sudden Death Genomics Labora-
ory, Guggenheim 5-11b, 200 First Street SW, Rochester, Min-
esota 55905. E-mail: bos.martijn@mayo.edu.
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